Walgreens’ clinical trials unit is shaping up to play a critical role in the retail pharmacy’s transformation strategy. This past year has been recovery mode for Walgreens, and more changes are coming. The company plans to shutter hundreds more of its drugstores over the next few years, in addition to rethinking its healthcare services portfolio, which includes primary and urgent care, specialty pharmacy and home care services. In an interview, Ramita Tandon, chief clinical trials officer at Walgreens, said the company’s clinical trials unit has big plans to reach more patients and will remain a key part of the company’s healthcare strategy.
Read the full article: How Walgreens Is Making Clinical Trials Part of Its Future Strategy //
Source: https://www.modernhealthcare.com/providers/walgreens-clinical-trials-ramita-tandon-barda-partnership-medical-research